Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by elgin1on Mar 22, 2017 2:35am

121 Views

Post# 26012014

RE:Current Research into Cures

It will be faster than you think. Sva is applying to treat non responsive hypoglycaemics which there is no cure . Not typical Type 1 diabetes so it will be fast tracked . They already have compatibility approval for the device ... it is made out of the same type of material stents and other devices currently approved. Once they file FDA has 30 days to respond to application. It won't be easy sailing but Sva have hired a firm that exclusively deals with FDA . Waiting for more info from Sva. Last I heard they were in the process of filing .

Bullboard Posts

Eminent acquires promising Nevada gold project